Two immunomodulators, curcumin and sulfasalazine, enhance IDV antiretroviral activity in HIV-1 persistently infected cells.

Riva, D A; Fernández-Larrosa, P N; Dolcini, G L; Martínez-Peralta, L A; Coulombié, F C; Mersich, S E

Riva, D A; Fernández-Larrosa, P N; Dolcini, G L; Martínez-Peralta, L A; Coulombié, F C; Mersich, S E.

Affiliation

Riva DA; Laboratory of Virology, Department of Biochemistry, School of Science, University of Buenos Aires, Int. Güiraldes 2160, Pab2 P4, Ciudad Universitaria, C1428EGA, Buenos Aires, Argentina. diegor@qb.fcen.uba.ar

Arch Virol ; 153(3): 561-5, 2008.

Article in En | MEDLINE | ID: mdl-18175040

Subject(s)

Anti-HIV Agents/pharmacology; CD4-Positive T-Lymphocytes/virology; Curcumin/pharmacology; HIV-1/drug effects; Indinavir/pharmacology; Sulfasalazine/pharmacology; Cell Line; Cell Survival/drug effects; Drug Synergism; Enzyme Inhibitors/pharmacology; HIV Core Protein p24/metabolism; HIV Protease Inhibitors/pharmacology; HIV-1/physiology; Humans; Protein Serine-Threonine Kinases/metabolism; NF-kappaB-Inducing Kinase

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sulfasalazine / CD4-Positive T-Lymphocytes / HIV-1 / Indinavir / Anti-HIV Agents / Curcumin Limits: Humans Language: En Journal: Arch Virol Year: 2008 Type: Article Affiliation country: Argentina

Fulltext

XML

PubMed Links

Search on Google